TreeWAS – Variant ID: rs2567519

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z00.0 General medical examination	0.000	0.920	0.080
J35.8 Other chronic diseases of tonsils and adenoids	0.038	0.962	0.000
D03.5 Melanoma in situ of trunk	0.000	0.983	0.017
J35 Chronic diseases of tonsils and adenoids	0.016	0.984	0.000
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.014	0.986	0.000
J35.0 Chronic tonsillitis	0.013	0.987	0.000
J35.2 Hypertrophy of adenoids	0.012	0.988	0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.011	0.988	0.000
O63.1 Prolonged second stage (of labour)	0.011	0.989	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.011	0.989	0.000
O63 Long labour	0.009	0.991	0.000
O63.0 Prolonged first stage (of labour)	0.009	0.991	0.000
O63.9 Long labour, unspecified	0.009	0.991	0.000
O63.2 Delayed delivery of second twin, triplet, etc.	0.007	0.993	0.000
D62 Acute posthaemorrhagic anaemia	0.006	0.994	0.000
M79.18 Myalgia (Other)	0.000	0.994	0.006
Z36.8 Other antenatal screening	0.000	0.994	0.006
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.000	0.994	0.005
R44.1 Visual hallucinations	0.000	0.994	0.006
Z36 Antenatal screening	0.000	0.994	0.006
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.994	0.005
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.995	0.005
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.995	0.005
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.005
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.995	0.005
M19.94 Arthrosis, unspecified (Hand)	0.000	0.995	0.005
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.995	0.005
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.995	0.005
Z00.3 Examination for adolescent development state	0.000	0.995	0.004
Z00.2 Examination for period of rapid growth in childhood	0.000	0.995	0.004
Z00.1 Routine child health examination	0.000	0.995	0.004
Z00.4 General psychiatric examination, not elsewhere classified	0.000	0.995	0.004
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.995	0.004
R44 Other symptoms and signs involving general sensations and perceptions	0.000	0.996	0.004
Z36.5 Antenatal screening for isoimmunisation	0.000	0.996	0.004
Y52 Agents primarily affecting the cardiovascular system	0.000	0.996	0.004
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.996	0.004
D03 Melanoma in situ	0.000	0.996	0.004
H81.1 Benign paroxysmal vertigo	0.000	0.996	0.004
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.000	0.996	0.004
D03.4 Melanoma in situ of scalp and neck	0.000	0.996	0.004
R44.0 Auditory hallucinations	0.000	0.996	0.004
O32.1 Maternal care for breech presentation	0.004	0.996	0.000
Z00.8 Other general examinations	0.001	0.996	0.003
R44.3 Hallucinations, unspecified	0.000	0.996	0.004
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.996	0.003
J35.1 Hypertrophy of tonsils	0.003	0.996	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.003	0.997	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.997	0.003
R44.2 Other hallucinations	0.000	0.997	0.003
D03.0 Melanoma in situ of lip	0.000	0.997	0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
D03.9 Melanoma in situ, unspecified	0.000	0.997	0.003
G91 Hydrocephalus	0.000	0.997	0.003
F43.1 Posttraumatic stress disorder	0.000	0.997	0.003
G91.8 Other hydrocephalus	0.000	0.997	0.003
G91.1 Obstructive hydrocephalus	0.000	0.997	0.003
H47.3 Other disorders of optic disk	0.000	0.997	0.003
Y40.0 Penicillins	0.000	0.997	0.003
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
G91.0 Communicating hydrocephalus	0.000	0.997	0.003
M05.9 Seropositive rheumatoid arthritis, unspecified	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
G91.2 Normal-pressure hydrocephalus	0.000	0.997	0.003
D03.1 Melanoma in situ of eyelid, including canthus	0.000	0.997	0.003
K83.0 Cholangitis	0.003	0.997	0.000
D03.8 Melanoma in situ of other sites	0.000	0.997	0.003
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.003	0.997	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.000	0.997	0.003
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.997	0.003
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
R25.1 Tremor, unspecified	0.000	0.997	0.003
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.997	0.003
Y52.7 Peripheral vasodilators	0.000	0.997	0.002
Y57.5 X-ray contrast media	0.000	0.997	0.003
Z00.6 Examination for normal comparison and control in clinical research programme	0.001	0.997	0.002
L89.1 Stage II decubitus ulcer	0.003	0.997	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
M79.1 Myalgia	0.000	0.997	0.003
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.003	0.997	0.000
T78.4 Allergy, unspecified	0.003	0.997	0.000
Z00.5 Examination of potential donor of organ and tissue	0.001	0.997	0.001
M79.16 Myalgia (Lower leg)	0.000	0.997	0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
K12.1 Other forms of stomatitis	0.000	0.997	0.003
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.002	0.997	0.000
O47.9 False labour, unspecified	0.002	0.997	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.000	0.998	0.002
G91.9 Hydrocephalus, unspecified	0.000	0.998	0.002
G96.0 Cerebrospinal fluid leak	0.000	0.998	0.002
Y57.6 Other diagnostic agents	0.000	0.998	0.002
C54.1 Endometrium	0.002	0.998	0.000
K82.4 Cholesterolosis of gallbladder	0.000	0.998	0.002
O47 False labour	0.002	0.998	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.002	0.998	0.000
O47.0 False labour before 37 completed weeks of gestation	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.000	0.998	0.002
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.000	0.998	0.002
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.000	0.998	0.002
O44.0 Placenta praevia specified as without haemorrhage	0.002	0.998	0.000
M79.17 Myalgia (Ankle and foot)	0.000	0.998	0.002
M79.14 Myalgia (Hand)	0.000	0.998	0.002
M79.13 Myalgia (Forearm)	0.000	0.998	0.002
M79.12 Myalgia (Upper arm)	0.000	0.998	0.002
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
M79.15 Myalgia (Pelvic region and thigh)	0.000	0.998	0.002
M79.11 Myalgia (Shoulder region)	0.000	0.998	0.002
J02.9 Acute pharyngitis, unspecified	0.000	0.998	0.002
S02.4 Fracture of malar and maxillary bones	0.000	0.998	0.002
M79.19 Myalgia (Site unspecified)	0.000	0.998	0.002
I07.1 Tricuspid insufficiency	0.002	0.998	0.000
S13.4 Sprain and strain of cervical spine	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
M05.8 Other seropositive rheumatoid arthritis	0.002	0.998	0.000
Y40 Systemic antibiotics	0.000	0.998	0.002
Y44.2 Anticoagulants	0.000	0.998	0.002
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
M05 Seropositive rheumatoid arthritis	0.002	0.998	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.998	0.002
Y57.7 Vitamins, not elsewhere classified	0.000	0.998	0.002
Y57.4 Pharmaceutical excipients	0.000	0.998	0.002
Y57.3 Alcohol deterrents	0.000	0.998	0.002
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
Y57.1 Lipotropic drugs	0.000	0.998	0.002
Y57.0 Appetite depressants [anorectics]	0.000	0.998	0.002
O45.9 Premature separation of placenta, unspecified	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.000	0.998	0.002
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.998	0.002
K74.3 Primary biliary cirrhosis	0.000	0.998	0.002
L98.4 Chronic ulcer of skin, not elsewhere classified	0.000	0.998	0.002
O32 Maternal care for known or suspected malpresentation of foetus	0.002	0.998	0.000
W22.9 Unspecified place	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.000	0.998	0.002
Y45.1 Salicylates	0.000	0.998	0.002
Y47.1 Benzodiazepines	0.000	0.998	0.002
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.998	0.002
Y44.6 Natural blood and blood products	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.998	0.002
L89.0 Stage I decubitus ulcer and pressure area	0.002	0.998	0.000
Y40.6 Rifamycins	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.002
F43 Reaction to severe stress, and adjustment disorders	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.998	0.001
Y40.3 Macrolides	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.002
Y44.7 Plasma substitutes	0.000	0.998	0.002
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.002
Y47 Sedatives, hypnotics and antianxiety drugs	0.000	0.998	0.002
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.000	0.998	0.002
O32.8 Maternal care for other malpresentation of foetus	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.000	0.998	0.002
Z82.0 Family history of epilepsy and other diseases of the nervous system	0.000	0.998	0.002
F43.9 Reaction to severe stress, unspecified	0.000	0.998	0.002
I97.1 Other functional disturbances following cardiac surgery	0.002	0.998	0.000
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
M05.88 Other seropositive rheumatoid arthritis (Other)	0.002	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.002	0.998	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
O32.6 Maternal care for compound presentation	0.002	0.998	0.000
O32.3 Maternal care for face, brow and chin presentation	0.002	0.998	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.000	0.998	0.002
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.000	0.998	0.002
Y40.2 Chloramphenicol group	0.000	0.998	0.002
B50.9 Plasmodium falciparum malaria, unspecified	0.000	0.998	0.002
M05.1 Rheumatoid lung disease	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
S92.40 Fracture of great toe (closed)	0.002	0.998	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.000	0.998	0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
K12.0 Recurrent oral aphthae	0.000	0.998	0.002
K82.2 Perforation of gallbladder	0.000	0.998	0.002
N83.2 Other and unspecified ovarian cysts	0.000	0.998	0.002
O32.9 Maternal care for malpresentation of foetus, unspecified	0.002	0.998	0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.002	0.998	0.000
L89 Decubitus ulcer	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
Y58 Bacterial vaccines	0.000	0.998	0.002
I05.2 Mitral stenosis with insufficiency	0.002	0.998	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.002	0.998	0.000
Y55.4 Expectorants	0.000	0.998	0.002
M05.20 Rheumatoid vasculitis (Multiple sites)	0.001	0.998	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.998	0.001
D48.6 Breast	0.002	0.998	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.998	0.002
S91.3 Open wound of other parts of foot	0.000	0.998	0.002
F43.2 Adjustment disorders	0.000	0.998	0.002
I05.1 Rheumatic mitral insufficiency	0.002	0.998	0.000
R86.8 Other abnormal findings	0.002	0.998	0.000
V89.9 Person injured in unspecified vehicle accident	0.000	0.998	0.002
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
H47.7 Disorder of visual pathways, unspecified	0.000	0.998	0.001
H47.6 Disorders of visual cortex	0.000	0.998	0.001
H47.4 Disorders of optic chiasm	0.000	0.998	0.001
K86.1 Other chronic pancreatitis	0.002	0.998	0.000
Y58.0 BCG vaccine	0.000	0.998	0.001
F43.8 Other reactions to severe stress	0.000	0.998	0.001
H47.1 Papilloedema, unspecified	0.000	0.998	0.002
Y40.4 Tetracyclines	0.000	0.998	0.001
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.001
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.001
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.001
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.001
Y51.0 Anticholinesterase agents	0.001	0.998	0.001
O45 Premature separation of placenta [abruptio placentae]	0.002	0.998	0.000
O44 Placenta praevia	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.000	0.998	0.002
M79.10 Myalgia (Multiple sites)	0.000	0.998	0.001
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.998	0.002
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.000	0.998	0.001
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.000	0.998	0.001
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.000	0.998	0.001
Y47.4 Bromine compounds	0.000	0.998	0.001
Y47.3 Paraldehyde	0.000	0.998	0.001
Y47.2 Chloral derivatives	0.000	0.998	0.001
Y47.0 Barbiturates, not elsewhere classified	0.000	0.998	0.001
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.998	0.002
M05.28 Rheumatoid vasculitis (Other)	0.001	0.998	0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)	0.001	0.998	0.000
M05.26 Rheumatoid vasculitis (Lower leg)	0.001	0.998	0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)	0.001	0.998	0.000
M05.24 Rheumatoid vasculitis (Hand)	0.001	0.998	0.000
M05.23 Rheumatoid vasculitis (Forearm)	0.001	0.998	0.000
M05.22 Rheumatoid vasculitis (Upper arm)	0.001	0.998	0.000
M05.21 Rheumatoid vasculitis (Shoulder region)	0.001	0.998	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.001
M77.95 Enthesopathy, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
H47.5 Disorders of other visual pathways	0.000	0.998	0.001
S20.3 Other superficial injuries of front wall of thorax	0.000	0.998	0.002
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.998	0.001
M05.09 Felty's syndrome (Site unspecified)	0.001	0.998	0.000
M05.08 Felty's syndrome (Other)	0.001	0.998	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.001	0.998	0.000
M05.06 Felty's syndrome (Lower leg)	0.001	0.998	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.001	0.998	0.000
M05.04 Felty's syndrome (Hand)	0.001	0.998	0.000
M05.03 Felty's syndrome (Forearm)	0.001	0.998	0.000
M05.02 Felty's syndrome (Upper arm)	0.001	0.998	0.000
M05.01 Felty's syndrome (Shoulder region)	0.001	0.998	0.000
M05.00 Felty's syndrome (Multiple sites)	0.001	0.998	0.000
M05.10 Rheumatoid lung disease (Multiple sites)	0.001	0.998	0.000
M05.29 Rheumatoid vasculitis (Site unspecified)	0.001	0.998	0.000
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.002	0.998	0.000
O32.2 Maternal care for transverse and oblique lie	0.001	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.000	0.998	0.002
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.001
G96 Other disorders of central nervous system	0.000	0.998	0.002
M05.19 Rheumatoid lung disease (Site unspecified)	0.001	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.001	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.001	0.998	0.000
M05.16 Rheumatoid lung disease (Lower leg)	0.001	0.998	0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)	0.001	0.998	0.000
M05.14 Rheumatoid lung disease (Hand)	0.001	0.998	0.000
M05.13 Rheumatoid lung disease (Forearm)	0.001	0.998	0.000
M05.12 Rheumatoid lung disease (Upper arm)	0.001	0.998	0.000
M05.11 Rheumatoid lung disease (Shoulder region)	0.001	0.998	0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)	0.001	0.998	0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)	0.001	0.998	0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)	0.001	0.998	0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)	0.001	0.998	0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)	0.001	0.998	0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)	0.001	0.998	0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)	0.001	0.998	0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)	0.001	0.998	0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)	0.001	0.998	0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)	0.001	0.998	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.002	0.998	0.000
D48.5 Skin	0.002	0.998	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.000	0.998	0.001
R22.2 Localised swelling, mass and lump, trunk	0.000	0.998	0.002
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.001
Y55.5 Anticommon cold drugs	0.000	0.998	0.001
Y55.3 Antitussives	0.000	0.998	0.001
Y55.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.001
Y55.0 Oxytocic drugs	0.000	0.998	0.001
C48.1 Specified parts of peritoneum	0.001	0.998	0.000
L89.3 Stage IV decubitus ulcer	0.001	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.000	0.998	0.001
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.000	0.998	0.001
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.000	0.998	0.001
Y58.5 Diphtheria vaccine	0.000	0.998	0.001
Y58.4 Tetanus vaccine	0.000	0.998	0.001
Y58.3 Plague vaccine	0.000	0.998	0.001
Y58.2 Cholera vaccine	0.000	0.998	0.001
Y58.1 Typhoid and paratyphoid vaccine	0.000	0.998	0.001
Z75.5 Holiday relief care	0.001	0.998	0.000
D48.7 Other specified sites	0.001	0.999	0.000
O43.8 Other placental disorders	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.000	0.999	0.001
Y50 Central nervous system stimulants, not elsewhere classified	0.000	0.999	0.001
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.999	0.001
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.001	0.999	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.000	0.999	0.001
C54.9 Corpus uteri, unspecified	0.001	0.999	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.000	0.999	0.001
I74.8 Embolism and thrombosis of other arteries	0.000	0.999	0.001
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.000	0.999	0.001
S62.30 Fracture of other metacarpal bone (closed)	0.000	0.999	0.001
F43.0 Acute stress reaction	0.000	0.999	0.001
K82.1 Hydrops of gallbladder	0.000	0.999	0.001
O33.5 Maternal care for disproportion due to unusually large foetus	0.001	0.999	0.000
O45.8 Other premature separation of placenta	0.001	0.999	0.000
O45.0 Premature separation of placenta with coagulation defect	0.001	0.999	0.000
R74.8 Abnormal levels of other serum enzymes	0.000	0.999	0.001
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.000	0.999	0.001
Y48.3 Local anaesthetics	0.000	0.999	0.001
K12 Stomatitis and related lesions	0.000	0.999	0.001
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.000	0.999	0.001
M13.00 Polyarthritis, unspecified (Multiple sites)	0.000	0.999	0.001
D37.4 Colon	0.000	0.999	0.001
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.999	0.001
K92.0 Haematemesis	0.000	0.999	0.001
I74 Arterial embolism and thrombosis	0.000	0.999	0.001
Y48 Anaesthetics and therapeutic gases	0.000	0.999	0.001
M43.17 Spondylolisthesis (Lumbosacral region)	0.001	0.999	0.000
D48.1 Connective and other soft tissue	0.001	0.999	0.000
G51.9 Disorder of facial nerve, unspecified	0.001	0.999	0.000
R26.3 Immobility	0.001	0.999	0.000
S91.1 Open wound of toe(s) without damage to nail	0.000	0.999	0.001
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.999	0.001
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.001	0.999	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.999	0.001
C54 Malignant neoplasm of corpus uteri	0.001	0.999	0.000
O46.8 Other antepartum haemorrhage	0.001	0.999	0.000
Y59.0 Viral vaccines	0.000	0.999	0.001
D48.4 Peritoneum	0.001	0.999	0.000
G96.9 Disorder of central nervous system, unspecified	0.000	0.999	0.001
G96.8 Other specified disorders of central nervous system	0.000	0.999	0.001
H43.2 Crystalline deposits in vitreous body	0.000	0.999	0.001
K92.9 Disease of digestive system, unspecified	0.000	0.999	0.001
S02.3 Fracture of orbital floor	0.000	0.999	0.001
Y45.5 4-Aminophenol derivatives	0.000	0.999	0.001
Y45.2 Propionic acid derivatives	0.000	0.999	0.001
O43 Placental disorders	0.001	0.999	0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.001	0.999	0.000
S37.00 Injury of kidney (without open wound into cavity)	0.001	0.999	0.000
K12.3 Oral mucositis (ulcerative)	0.000	0.999	0.001
Y42.0 Glucocorticoids and synthetic analogs	0.000	0.999	0.001
Y50.9 Central nervous system stimulant, unspecified	0.000	0.999	0.001
Y50.8 Other central nervous system stimulants	0.000	0.999	0.001
Y50.1 Opioid receptor antagonists	0.000	0.999	0.001
Y50.0 Analeptics	0.000	0.999	0.001
Y59.9 Vaccine or biological substance, unspecified	0.000	0.999	0.001
Y59.8 Other specified vaccines and biological substances	0.000	0.999	0.001
Y59.2 Protozoal vaccines	0.000	0.999	0.001
Y59.1 Rickettsial vaccines	0.000	0.999	0.001
I05 Rheumatic mitral valve diseases	0.001	0.999	0.000
H47.2 Optic atrophy	0.000	0.999	0.001
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.999	0.001
S52.70 Multiple fractures of forearm (closed)	0.000	0.999	0.001
D48.3 Retroperitoneum	0.001	0.999	0.000
O32.4 Maternal care for high head at term	0.001	0.999	0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.001	0.999	0.000
Q44.6 Cystic disease of liver	0.001	0.999	0.000
V89.3 Person injured in unspecified nonmotor-vehicle accident, traffic	0.000	0.999	0.001
V89.1 Person injured in unspecified nonmotor-vehicle accident, nontraffic	0.000	0.999	0.001
V89.0 Person injured in unspecified motor-vehicle accident, nontraffic	0.000	0.999	0.001
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.999	0.001
Y83.3 Surgical operation with formation of external stoma	0.000	0.999	0.001
I21.0 Acute transmural myocardial infarction of anterior wall	0.001	0.999	0.000
Y45.8 Other analgesics and antipyretics	0.000	0.999	0.001
Y45.4 Antirheumatics	0.000	0.999	0.001
Y48.5 Therapeutic gases	0.000	0.999	0.001
Y48.1 Parenteral anaesthetics	0.000	0.999	0.001
Y48.0 Inhaled anaesthetics	0.000	0.999	0.001
I07 Rheumatic tricuspid valve diseases	0.001	0.999	0.000
K82 Other diseases of gallbladder	0.000	0.999	0.001
S91 Open wound of ankle and foot	0.000	0.999	0.001
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.999	0.001
C17.0 Duodenum	0.000	0.999	0.001
C54.8 Overlapping lesion of corpus uteri	0.001	0.999	0.000
C54.3 Fundus uteri	0.001	0.999	0.000
C54.2 Myometrium	0.001	0.999	0.000
C54.0 Isthmus uteri	0.001	0.999	0.000
O43.9 Placental disorder, unspecified	0.001	0.999	0.000
S49.9 Unspecified injury of shoulder and upper arm	0.001	0.999	0.000
Y42.1 Thyroid hormones and substitutes	0.000	0.999	0.001
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.000	0.999	0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.000	0.999	0.001
L50.8 Other urticaria	0.000	0.999	0.001
Q61.5 Medullary cystic kidney	0.001	0.999	0.000
S46.0 Injury of tendon of the rotator cuff of shoulder	0.001	0.999	0.000
Y42.9 Other and unspecified hormone antagonists	0.000	0.999	0.001
O33 Maternal care for known or suspected disproportion	0.001	0.999	0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.001	0.999	0.000
S02.31 Fracture of orbital floor (open)	0.000	0.999	0.001
I05.9 Mitral valve disease, unspecified	0.001	0.999	0.000
N90.4 Leukoplakia of vulva	0.001	0.999	0.000
O43.2 Morbidly adherent placenta	0.001	0.999	0.000
W13.9 Unspecified place	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.999	0.001
Y42.2 Antithyroid drugs	0.000	0.999	0.001
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.999	0.001
Y50.2 Methylxanthines, not elsewhere classified	0.000	0.999	0.001
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.999	0.001
K82.9 Disease of gallbladder, unspecified	0.000	0.999	0.001
Q61.3 Polycystic kidney, unspecified	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.999	0.001
Y53 Agents primarily affecting the gastro-intestinal system	0.000	0.999	0.001
S36.10 Injury of liver or gallbladder (without open wound into cavity)	0.000	0.999	0.001
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.001	0.999	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.001	0.999	0.000
S91.2 Open wound of toe(s) with damage to nail	0.000	0.999	0.001
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y49.9 Psychotropic drug, unspecified	0.000	0.999	0.001
Y49.7 Psychostimulants with abuse potential	0.000	0.999	0.001
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.999	0.001
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.999	0.001
M77.93 Enthesopathy, unspecified (Forearm)	0.001	0.999	0.000
E55.9 Vitamin D deficiency, unspecified	0.001	0.999	0.000
H43.8 Other disorders of vitreous body	0.000	0.999	0.001
I07.9 Tricuspid valve disease, unspecified	0.001	0.999	0.000
I07.8 Other tricuspid valve diseases	0.001	0.999	0.000
I07.2 Tricuspid stenosis with insufficiency	0.001	0.999	0.000
I07.0 Tricuspid stenosis	0.001	0.999	0.000
J06.9 Acute upper respiratory infection, unspecified	0.000	0.999	0.001
L89.2 Stage III decubitus ulcer	0.001	0.999	0.000
O44.1 Placenta praevia with haemorrhage	0.001	0.999	0.000
S40.0 Contusion of shoulder and upper arm	0.000	0.999	0.001
S91.7 Multiple open wounds of ankle and foot	0.000	0.999	0.001
Y46.8 Antispasticity drugs	0.000	0.999	0.001
Y46.7 Anti-Parkinsonism drugs	0.000	0.999	0.001
Y46.3 Deoxybarbiturates	0.000	0.999	0.001
Y46.1 Oxazolidinediones	0.000	0.999	0.001
Y46.0 Succinimides	0.000	0.999	0.001
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.999	0.001
Y53.3 Saline and osmotic laxatives	0.000	0.999	0.001
Y54.9 Mineral salts, not elsewhere classified	0.000	0.999	0.001
Y54.6 Electrolytic, caloric and water-balance agents	0.000	0.999	0.001
Y54.2 Carbonic-anhydrase inhibitors	0.000	0.999	0.001
Y59.3 Immunoglobulin	0.000	0.999	0.001
O35 Maternal care for known or suspected foetal abnormality and damage	0.001	0.999	0.000
S72.20 Subtrochanteric fracture (closed)	0.001	0.999	0.000
B17.1 Acute hepatitis C	0.001	0.999	0.000
C17.2 Ileum	0.000	0.999	0.001
I74.5 Embolism and thrombosis of iliac artery	0.000	0.999	0.001
M77.9 Enthesopathy, unspecified	0.001	0.999	0.000
O33.8 Maternal care for disproportion of other origin	0.001	0.999	0.000
O33.7 Maternal care for disproportion due to other foetal deformities	0.001	0.999	0.000
O33.6 Maternal care for disproportion due to hydrocephalic foetus	0.001	0.999	0.000
O33.4 Maternal care for disproportion of mixed maternal and foetal origin	0.001	0.999	0.000
O33.3 Maternal care for disproportion due to outlet contraction of pelvis	0.001	0.999	0.000
O33.2 Maternal care for disproportion due to inlet contraction of pelvis	0.001	0.999	0.000
O33.1 Maternal care for disproportion due to generally contracted pelvis	0.001	0.999	0.000
O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones	0.001	0.999	0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.001	0.999	0.000
O43.1 Malformation of placenta	0.001	0.999	0.000
O43.0 Placental transfusion syndromes	0.001	0.999	0.000
Q61.9 Cystic kidney disease, unspecified	0.001	0.999	0.000
R86.7 Abnormal histological findings	0.001	0.999	0.000
X51.9 Unspecified place	0.000	0.999	0.001
Y40.8 Other systemic antibiotics	0.000	0.999	0.001
Y56.9 Topical agent, unspecified	0.000	0.999	0.001
Y56.8 Other topical agents	0.000	0.999	0.001
Y56.7 Dental drugs, topically applied	0.000	0.999	0.001
Y56.6 Otorhinolaryngological drugs and preparations	0.000	0.999	0.001
Y56.5 Ophthalmological drugs and preparations	0.000	0.999	0.001
Y56.2 Local astringents and local detergents	0.000	0.999	0.001
Y56.1 Antipruritics	0.000	0.999	0.001
M77.92 Enthesopathy, unspecified (Upper arm)	0.001	0.999	0.000
C67.4 Posterior wall of bladder	0.001	0.999	0.000
I05.8 Other mitral valve diseases	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.001
Y54.0 Mineralocorticoids	0.000	0.999	0.001
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.999	0.001
R86 Abnormal findings in specimens from male genital organs	0.001	0.999	0.000
H27.0 Aphakia	0.001	0.999	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.999	0.001
N91.2 Amenorrhoea, unspecified	0.000	0.999	0.001
S90.8 Other superficial injuries of ankle and foot	0.000	0.999	0.001
Y40.9 Systemic antibiotic, unspecified	0.000	0.999	0.001
Y42.4 Oral contraceptives	0.000	0.999	0.001
Y46.6 Other and unspecified antiepileptics	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations